The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed)
The summary for the The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed): This Notice of Funding Opportunity (NOFO) invites applications to participate as the Data Coordinating Center (DCC) for the Stillbirth Research Consortium. The DCC will assist the work of the research projects funded in the companion announcement (see RFA-HD-25-010) and will provide management and support for the Consortium. DCC staff must possess strong scientific qualifications, including but not limited to, expertise in clinical/health informatics, bioinformatics, -omics, biostatistics, epidemiology, and data science. DCC personnel must have experience in the supervision of clinical studies, as well as experience in the statistical analysis of high-volume demographic, clinical, laboratory, and imaging data, and experience working with large national datasets. The DCC and Research Centers together will establish an integrated and collaborative Stillbirth Research Consortiumto support cutting-edge basic, translational, clinical and/or data sciences research to generate knowledge for advancement in stillbirth-relevant research across the United States, with a particular emphasis on approaches that utilize an equity lens to identify ways to decrease the incidence of stillbirth in vulnerable populations.
Federal Grant Title: | The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health, Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HD-25-011 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.865 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 1st, 2024 |
Original Application Deadline: | November 1st, 2024 |
Posted Date: | July 19th, 2024 |
Creation Date: | July 19th, 2024 |
Archive Date: | December 7th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | July 19th, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-011.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
- • Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional)
- • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - ...
- • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - ...
- • Contraceptive Development Research Centers (P50 Clinical Trial Optional)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...
- • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...
- • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)